治疗后的免疫媒介性瘤性肌肉病:一个促成因素?
Brian Lam1, Eleni Tiniakou1, Xinhai Robert Zhang1
1UTHealth Houston, Houston, TX, USA.
BMJ case reports
|March 5, 2026
概括
这份病例报告详细介绍了一名患者,该患者在服用西马格卢提德后出现了免疫媒介性缩肌病 (IMNM). 治疗涉及免疫抑制,导致症状改善和功能恢复.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫媒介性缩肌病 (IMNM) 是一种罕见的自身免疫性疾病,影响肌肉.
- 药物诱导的肌肉病变越来越被认可,需要对潜在的触发因素进行调查.
- 作为一种类似葡萄糖类-1 (GLP-1) 受体激动剂的塞马格卢提德,广泛用于2型糖尿病和肥胖症.
研究的目的:
- 报告与西马格卢提德使用相关的第一个可能的IMNM病例.
- 描述该患者的临床表现,诊断结果和治疗反应.
- 提高临床医生对潜在的GLP-1受体激素因子相关肌病的认识.
主要方法:
- 一个60多岁的女性患者的详细临床病例描述.
- 对诊断工作的审查,包括肌肉活检和实验室测试 (肌酸激酶).
- 用皮质类固醇和静脉注射免疫球蛋白 (IVIG) 治疗的记录以及患者的反应.
主要成果:
- 患者呈现出渐进的消化不良,失声症,近端肌肉衰弱和肌酸激酶水平升高的情况.
- 肌肉活检证实了带有炎症透的死结肌病.
- 免疫抑制疗法 (皮质类固醇和IVIG) 改善了症状,患者在避免服用西马格卢类药物后恢复了功能状态.
结论:
- 这一案例表明,塞马格卢提德使用与IMNM的发展之间可能存在关联.
- 早期诊断和免疫抑制治疗,包括IVIG,可能会带来有利的结果.
- 持续警和报告对于理解与GLP-1受体激动剂相关的药物诱导肌病至关重要.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
01:15Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
01:28Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
01:14Myocarditis III: Medical Management
276
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
276